日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助帕博西尼联合内分泌治疗与化疗治疗ER+/HER2-乳腺癌:一项随机II期试验

Matikas, Alexios; Tzoras, Evangelos; Sarafidis, Michail; Sifakis, Emmanouil G; Bjöhle, Judith; Barnekow, Elin; Margolin, Sara; Isaksson-Friman, Erika; Kessler, Luisa Edman; Zouzos, Athanasios; Johansson, Hemming; Hellström, Mats; Agartz, Susanne; Grybäck, Per; Salgkamis, Dimitrios; Zerdes, Ioannis; Wang, Kang; Hartman, Johan; Acs, Balazs; Sun, Wenwen; Boyaci, Ceren; Villacampa, Guillermo; Pascual, Tomas; Gavila, Joaquin; Prat, Aleix; Perou, Charles; Brandberg, Yvonne; Bergh, Jonas; Hatschek, Thomas; Foukakis, Theodoros

Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironment

空间分辨的T细胞受体多样性图谱揭示了癌症免疫微环境的变异性

Magoulopoulou, Anastasia; Chatzinikolaou, Maria; Metousis, Andreas; Hu, Taobo; Yu, Hui; Zerdes, Ioannis; Wang, Kang; Foukakis, Theodoros; Long, Mengping; Leandersson, Karin; Micke, Patrick; Strell, Carina; Nilsson, Mats

Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort study

乳腺癌患者新辅助治疗期间肿瘤Ki-67动态变化的预后意义:一项基于人群的队列研究

Toli, Maria Angeliki; Liu, Xingrong; Massa, Davide; Lando, Stefania; Boman, Caroline; Tsiknakis, Nikolaos; Tranchell, Christian; Papakonstantinou, Andri; Fotia, Giuseppe; Vernieri, Claudio; Guarneri, Valentina; Bergh, Jonas; Dieci, Maria Vittoria; Bergman, Louise Eriksson; Matikas, Alexios; Foukakis, Theodoros

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial

乳腺癌辅助化疗剂量密集型方案的获益:来自随机3期PANTHER试验的亚组分析

Matikas, Alexios; Papakonstantinou, Andri; Loibl, Sibylle; Steger, Günther G; Untch, Michael; Johansson, Hemming; Tsiknakis, Nikos; Hellström, Mats; Greil, Richard; Möbus, Volker; Gnant, Michael; Bergh, Jonas; Foukakis, Theodoros

Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study

符合辅助阿贝西利或瑞博西尼治疗条件的乳腺癌患者的患病率和预后:一项全国性人群研究

Liu, Xingrong; Binicy, Behnaz; Acs, Balazs; Eriksson Bergman, Louise; Loibl, Sibylle; Gnant, Michael; Untch, Michael; Valachis, Antonios; Bergh, Jonas; Hartman, Johan; Foukakis, Theodoros; Matikas, Alexios

Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort study

接受包括GnRH类似物在内的辅助内分泌治疗的依从性与生存率:一项基于人群的队列研究

Eriksson Bergman, Louise; Matikas, Alexios; Liu, Xingrong; Foukakis, Theodoros

Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study

利用机器学习模型优化复发风险/Prosigna检测指南:一项瑞典多中心研究

Kjällquist, Una; Tsiknakis, Nikos; Acs, Balazs; Margolin, Sara; Kessler, Luisa Edman; Levy, Scarlett; Ekholm, Maria; Lundgren, Christine; Olsson, Erik; Lindman, Henrik; Valachis, Antonios; Hartman, Johan; Foukakis, Theodoros; Matikas, Alexios

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

基于机器学习的肿瘤免疫微环境空间特征分析在 EORTC 10994/BIG 1-00 早期乳腺癌试验中的应用

Zerdes, Ioannis; Matikas, Alexios; Mezheyeuski, Artur; Manikis, Georgios; Acs, Balazs; Johansson, Hemming; Boyaci, Ceren; Boman, Caroline; Poncet, Coralie; Ignatiadis, Michail; Bai, Yalai; Rimm, David L; Cameron, David; Bonnefoi, Hervé; Bergh, Jonas; MacGrogan, Gaetan; Foukakis, Theodoros

Comprehensive genome profiling for treatment decisions in patients with metastatic tumors: real-world evidence meta-analysis and registry data implementation

针对转移性肿瘤患者的治疗决策,进行全面的基因组分析:真实世界证据荟萃分析和注册数据应用

Zerdes, Ioannis; Filis, Panagiotis; Fountoukidis, Georgios; El-Naggar, Ali Inan; Kalofonou, Foteini; D'Alessio, Antonio; Pouptsis, Athanasios; Foukakis, Theodoros; Pentheroudakis, George; Ahlgren, Johan; Smith, Daniel; Valachis, Antonios

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

高危早期三阴性乳腺癌患者新辅助帕博利珠单抗联合化疗疗效的分子决定因素:一项开放标签、多队列 1b 期 KEYNOTE-173 研究的探索性分析

Dent, Rebecca; Cortés, Javier; Park, Yeon Hee; Muñoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kümmel, Sherko; Yearley, Jennifer; Wang, Anran; Nebozhyn, Michael; Huang, Lingkang; Cristescu, Razvan; Jelinic, Petar; Karantza, Vassiliki; Schmid, Peter